Memantine attenuated alcohol withdrawal-induced anxiety-like behaviors through down-regulating NR1-CaMKII-ERK signaling pathway

Neurosci Lett. 2018 Nov 1:686:133-139. doi: 10.1016/j.neulet.2018.09.006. Epub 2018 Sep 10.

Abstract

Alcohol abuse and anxiety disorders often occur concurrently, but their underlying cellular mechanisms remain unclear. N-methyl-D-aspartic acid receptors (NMDARs) have recently received attention from those interested in the neurobiology of anxiety. A chronic alcohol exposure rat model (28 consecutive days of 20% alcohol intake and 6 h of withdrawal) was established. Here, we investigated the NMDAR1 (NR1), Ca2+/calmodulin-dependent protein kinase II (CaMKII) and extracellular signal-regulated kinases (ERK) pathway in the modulation of anxiety-like behaviors in rats exposed to an open field and elevated plus maze (EPM) through systematic injections of memantine (a NMDAR inhibitor). We found that the NR1-CaMKII-ERK signaling pathway was activated after alcohol withdrawal in medial prefrontal cortex (mPFC) and nucleus accumbens shell (NAcSh) but not core (NAcC). Memantine treatment greatly ameliorated anxiety-like behavior in the rats experiencing alcohol withdrawal. Moreover, memantine uniformly suppressed the phosphorylation of NR1-CaMKII-ERK pathway induced by alcohol withdrawal. Our results suggest that activation of the NR1-CaMKII-ERK pathway in the mPFC and NAcSh is an important contributor to the molecular mechanisms underlying alcohol withdrawal-induced anxiety behaviors. NMDAR signaling pathway inhibitors are thus potential therapeutics for treating alcohol abuse.

Keywords: Anxiety; Memantine; N-methyl-d-aspartic acid receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcoholism / drug therapy
  • Alcoholism / metabolism
  • Animals
  • Anxiety / chemically induced
  • Anxiety / drug therapy
  • Anxiety Disorders / drug therapy
  • Anxiety Disorders / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / drug effects*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism
  • Ethanol / adverse effects*
  • Extracellular Signal-Regulated MAP Kinases / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Male
  • Memantine / pharmacology*
  • Phosphorylation / drug effects
  • Rats, Sprague-Dawley
  • Substance Withdrawal Syndrome / drug therapy*
  • Substance Withdrawal Syndrome / metabolism

Substances

  • Ethanol
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Extracellular Signal-Regulated MAP Kinases
  • Memantine